Indee Labs
Indee Labs focuses on the development of microfluidic vortex shedding for rapidly and efficiently transfecting human primary immune cells with negligible perturbation. The team is focused on developing its core technology for short turnaround chimeric antigen receptor T cell (CAR-T) development and manufacturing.
5
Funding Rounds
$5.1m
Money raised
Overview
Indee Labs focuses on the development of microfluidic vortex shedding for rapidly and efficiently transfecting human primary immune cells with negligible perturbation. The team is focused on developing its core technology for short turnaround chimeric antigen receptor T cell (CAR-T) development and manufacturing.
| Name | Phone | Social networks | |
|---|---|---|---|
| Ry** Pa**** |
|
- | linkedin twitter |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ry** Pa**** |
|
- | linkedin twitter |
Industries
Indee Labs is active in the following industries:
- Biopharmaceutical
- Genetics
- Medical device
- Regenerative medicine
- Cancer immunotherapy
- Immunotherapy
- Genetic engineering
- Therapeutics
- Oncology
- Cell therapy
- Drug discovery
- Biomedical engineering
- Medicine
- Technology
- Synthetic biology
- Biology
- Biotechnology
- Healthcare
- Internal medicine
- Health technology
- Engineering
- T cell